Adamas to Announce First Quarter 2017 Financial Results and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
53
Adamas to Announce First Quarter 2017 Financial Results and Host Conference Call on May 9, 2017

EMERYVILLE, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the company will report first quarter 2017 financial results on Tuesday, May 9, 2017 after market close. Subsequently, Adamas’ management team will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the financial results and provide a corporate update.

Investor Conference Call and Webcast The conference call can be accessed by dialing 844-215-3280 for participants in the U.S. or Canada and 484-747-6383 for international callers. The webcast can be accessed live via the investor section of the Adamas website at http://ir.adamaspharma.com/events.cfm and will be available for replay until June 9, 2017.

About Adamas Pharmaceuticals, Inc. Adamas develops new medicines to improve the daily lives of those affected by chronic neurologic disorders, including Parkinson's disease, multiple sclerosis, epilepsy, and Alzheimer's disease. Adamas has pioneered a platform to develop medicines, called chrono-synchronous therapies, for chronic neurologic disorders based on an understanding of the time-dependent biologic processes responsible for disease activity and drug response to potentially achieve symptomatic relief without tolerability issues. The company's most advanced product candidate, ADS-5102, is in development for levodopa-induced dyskinesia (LID) in people with Parkinson's disease and walking impairment in people with multiple sclerosis. A New Drug Application supporting ADS-5102 for the treatment of LID in people with Parkinson's disease is under review by the U.S. Food and Drug Administration, with a Prescription Drug User Fee Act (PDUFA) date of August 24, 2017. Adamas is exploring other indications for ADS-5102 for further development. Adamas is also investigating ADS-4101 for the treatment of partial onset seizures in patients with epilepsy. Additionally, Adamas’ licensed assets, are currently marketed by Allergan under the brand names NAMENDA XR ® and NAMZARIC ® , and Adamas is eligible to receive royalties on sales of these medicines beginning in June 2018 and May 2020, respectively. For more information, please visit www.adamaspharma.com .

NAMENDA XR ® and NAMZARIC ® are trademarks of Merz Pharma GmbH & Co. KGaA.

Contact: Martin Forrest Vice President, Corporate Communications & Investor Relations Adamas Pharmaceuticals, Inc. Phone: 510-450-3528 Email: ir@adamaspharma.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Buffett Steps Down, New Faces at Berkshire Hathaway

Updated Category News Views 4

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Continue Reading
ETERC's Ele Aims to Revolutionize STEM Education for All

Updated Category News Views 6

The AI Mentor Battleground in Education Ever found yourself wondering how public schools could step up their game without dumping money down the tech rabbit hole? ETERC’s latest push with Ele may just be a game-changer for them. We're not talking about your run-of-the-mill chatbot regurgitating facts from the internet—this is an AI tricked out for personalized...

Continue Reading
GenAI Boosts Grades and Tech Savvy for Online Learners

Updated Category News Views 2

What's Really Driving GenAI Use in Online Education? Let's not beat around the bush—most folks think students turn to this newfangled generative AI mainly to smooth over academic hurdles or save time. But guess what? The University of Phoenix has gone and poked some holes in that assumption. Study Highlights Key Insights This solid piece of research from the...

Continue Reading
Calavera NY Website Revamp: Gemstone Expansion Hits

Updated Category News Views 5

Calavera New York's Bold Online Makeover When a jewelry brand that's all about slashing retail markups makes a move this big, it's worth a real close-up look. Calavera New York, a name buzzing in the diamond and gemstone scene, just dropped a redesigned website that’s turning more than a few heads. They’re known for cutting out the middleman, a strategy that already...

Continue Reading
Debt Crisis Looms: Social Security at Risk

Updated Category News Views 4

Debt Reality: A National Concern with Global Implications When it comes to the U.S. federal debt situation, the latest report from the National Seniors Policy Center is lighting a fire like no other, warning us that we're not crying wolf here. We've got fiscal numbers that may not sit well at breakfast. With roughly 67 cents of every new buck Uncle Sam borrows going to...

Continue Reading
Menopause Policy Advocacy Takes Center Stage in DC

Updated Category News Views 5

Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...

Continue Reading
Sierra Ridge Advisors Join Gateway Financial Milestone

Updated Category News Views 5

Big Moves in the Financial Advisory World Let's dive right in. Here's a real shakeup in the advisory realm: 28 financial advisors and team members from Sierra Ridge Advisor Group are packing their bags for Gateway Financial Partners. We're talking about a significant shift involving $825 million in assets under advisement. Instead of sticking with Sierra Ridge as it...

Continue Reading
Heafner Takes Helm at HGTC Amid Strategic Shifts

Updated Category News Views 1

A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...

Continue Reading
Bascom's Strategic Play on a Dallas Apartment Deal

Updated Category News Views 8

Unpacking Bascom's Jasmine Acquisition In a market that's been more slippery than a greased pig, Bascom Group's move buying up Jasmine Apartments is capturing some eyes. Situated in North Dallas, this 370-unit complex ain't just another brick in the wall—it's Bascom's 42nd entry into Texas, reinforcing their knack for sniffing out deals others might tiptoe around,...

Continue Reading
Arizona Voters Demand Clear Plans for 2026 Election

Updated Category News Views 3

A Shift in Voter Expectations: Clear Actions Needed Arizona voters have spoken, and they aren't looking for the same old political song and dance anymore. They crave something meatier—action, not just words. Heading into the 2026 general election, folks in the Grand Canyon State are demanding concrete solutions and straightforward answers from those who seek to lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Promising Energy Stocks for Growth in 2023

Updated Category News Views 206

Opportunity in Oversold Energy Stocks In the dynamic world of the energy sector, certain stocks are presenting unique buying opportunities as they become increasingly undervalued. This analysis aims to illuminate the potential for growth among these oversold stocks. Understanding the RSI Indicator The Relative Strength Index (RSI) is a key momentum indicator that helps...

Continue Reading
Taylor Farms and Foodiverse Unite for Salad Operations Growth

Updated Category News Views 191

Key Acquisition by Taylor Farms and Foodiverse Foodiverse will manage all activities for the unified businesses. Taylor Farms and Foodiverse have successfully acquired two production plants that specialize in ready-to-eat salads from Bonduelle's fresh sector in Germany. This acquisition allows Foodiverse to consolidate its operations and enhance its influence in the...

Continue Reading
Fast Fresh Brands Selects USIM for Innovative Media Strategy

Updated Category News Views 174

Fast Fresh Brands Selects USIM as Media Agency of Record Fast Fresh Brands (FFB), known for its health-centric quick-service restaurant concepts such as Bee Healthy Café and Nature's Table, has appointed USIM as its media agency of record. This partnership aims to leverage innovative strategies that will help elevate FFB's brand visibility and reach, connecting with...

Continue Reading
Genmab Highlights Epcoritamab's Promise in Hematology Research

Updated Category News Views 48

Genmab Unveils Epcoritamab Innovations at ASH 2024 At the much-anticipated conference, the 66th Annual Meeting of the American Society of Hematology (ASH), Genmab A/S (Nasdaq: GMAB) showcased its advancements in the development of epcoritamab-bysp (known commercially as EPKINLY®). This revolutionary T-cell engaging bispecific antibody is administered subcutaneously and...

Continue Reading
TScan Therapeutics Secures Funding Surge with Warrant Sale

Updated Category News Views 83

TScan Therapeutics Secures $30 Million Funding TScan Therapeutics has successfully secured a substantial investment of $30 million through the sale of warrants. Jason A. Amello, the Chief Financial Officer of TScan, emphasized the critical role this funding will play in extending the company's financial runway. With these additional gross proceeds, TScan anticipates its...

Continue Reading